OptiMap:Precision Tumor Mapping Algorithm for Solid Tumor Molecular Testing

被引：0
|
作者：
Ghatak, S. [1 ]
Diks, J. [1 ]
Chowdhuri, S. Roy [1 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
TT010
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [31] Pragmatic precision oncology: the secondary uses of clinical tumor molecular profiling
    Rioth, Matthew J.
    Thota, Ramya
    Staggs, David B.
    Johnson, Douglas B.
    Warner, Jeremy L.
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2016, 23 (04) : 773 - 776
  • [32] Impact of Molecular Tumor Board (MTB) on precision oncology in a community setting
    ElNaggar, Adam
    Vidal, Gregory
    VanderWalde, Ari
    Schwartzberg, Lee
    Grothey, Axel
    Vaena, Daniel
    Bufalino, Gabriella
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S180 - S180
  • [33] Implementation of Pain Management Algorithm in Hospitalized Solid Tumor Patients
    Argiropoulos, Aliki
    Olsen, Mikaela
    Robinson, Maria
    Seidl, Kristin
    JOURNAL OF PAIN, 2024, 25 (04): : 33 - 34
  • [34] The molecular tumor board: a tool for the governance of precision oncology in the real world
    Incorvaia, Lorena
    Russo, Antonio
    Cinieri, Saverio
    TUMORI JOURNAL, 2022, 108 (04): : 288 - 290
  • [35] Molecular Tumor Profiling Using NGS: An Approach towards Precision Medicine
    Saha, K.
    Banerjee, S.
    Gupta, P.
    Majhi, P.
    Santra, P.
    Pal, B.
    Choudhury, S.
    Mukherjee, G.
    Mallath, M.
    Achari, R.
    Biswas, B.
    Dabkara, D.
    Ganguly, S.
    Ghosh, J.
    Arunsingh, M.
    Chatterjee, S.
    Zameer, L.
    Roy, P.
    Mishra, D.
    Arora, N.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (03): : S52 - S52
  • [36] Mapping the molecular communication within the tumor microenvironment of pancreatic cancer as well as between tumor and peritumoral tissue
    Alhamdani, Mohamed S.
    Bauer, Andrea S.
    Hoheisel, Joerg D.
    CANCER RESEARCH, 2017, 77
  • [37] Clinical integration of germline findings from a tumor testing precision medicine program
    Sanabria-Salas, Maria Carolina
    Anggala, Nina C.
    Gillies, Brittany
    Farncombe, Kirsten M.
    Hofstedter, Renee
    Peck, Larissa
    Purnaghshband, Helia
    Redondo, Laura
    Thain, Emily
    Xu, Wei
    Sabatini, Peter
    Bedard, Philippe L.
    Kim, Raymond H.
    BMC CANCER, 2025, 25 (01)
  • [38] Precision Medicine and Testing for Tumor-Biomarkers Are All Tests Born Equal?
    Hayes, Daniel F.
    JAMA ONCOLOGY, 2018, 4 (06) : 773 - 774
  • [39] Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid Tumor
    Schienda, Jaclyn
    Church, Alanna J.
    Corson, Laura B.
    Decker, Brennan
    Clinton, Catherine M.
    Manning, Danielle K.
    Imamovic-Tuco, Alma
    Reidy, Deirdre
    Strand, Gianna R.
    Applebaum, Mark A.
    Bagatell, Rochelle
    DuBois, Steven G.
    Glade-Bender, Julia L.
    Kang, Wenjun
    Kim, AeRang
    Laetsch, Theodore W.
    Macy, Margaret E.
    Maese, Luke
    Pinto, Navin
    Sabnis, Amit J.
    Schiffman, Joshua D.
    Colace, Susan, I
    Volchenboum, Samuel L.
    Weiser, Daniel A.
    Nowak, Jonathan A.
    Lindeman, Neal, I
    Janeway, Katherine A.
    Crompton, Brian D.
    Kamihara, Junne
    JCO PRECISION ONCOLOGY, 2021, 5 : 1840 - 1852
  • [40] Evolving or immutable - phase I solid tumor trials in the era of precision oncology
    Stockton, Shannon S.
    Ayers, G. Dan
    Lee, Cody
    Laferriere, Heather
    Das, Satya
    Berlin, Jordan
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (03) : 326 - 334
12345